|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| DAFNA Capital Management LLC
✚
|
|
|---|---|
| CRD # | 129053 |
| SEC # | 801-62559 |
| CIK # | 0001389933 |
| AUM | $537.7 M (2025-03-28) |
| Employees | 8 (88% Investors, 0% Brokers) |
| Phone | 310-954-3200 |
| Address | 10990 Wilshire Boulevard Los Angeles, CA 90024 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Stereotaxis Inc | 29.0 | ||
| Revolution Medicines Inc | 24.9 | ||
| Merus NV | 21.0 | ||
| AtriCure Inc | 19.4 | ||
| Cytokinetics Inc | 13.2 | ||
| IDEAYA Biosciences Inc | 13.0 | ||
| Ascendis Pharma A/S | 12.5 | ||
| Xenon Pharmaceuticals Inc | 9.0 | ||
| Neurocrine Biosciences Inc | 8.9 | ||
| Lectec Corp /MN/ | 8.0 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | DAFNA Fund LP Series A | [2012-03-29] | 278.8 | 217.0 |
| HF | DAFNA Fund LP Series B | [2012-03-29] | 278.8 | 0.5 |
| HF | DAFNA Fund LP Series C | [2012-03-29] | 278.8 | 120.6 |
| HF | DAFNA International Fund Ltd Class A | 2012-03-29 | 165.1 | |
| HF | DAFNA International Fund Ltd Class B | 2012-03-29 | 0.0 | |
| HF | DAFNA International Fund Ltd Class C | 2012-03-29 | 31.1 | |
| HF | DAFNA Lifescience LP | 2012-03-29 | 385.7 | |
| HF | DAFNA Lifescience Market Neutral LP | 2012-03-29 | 0.5 | |
| HF | DAFNA Lifescience Select LP | 2012-03-29 | 152.0 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 537.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 537.7 |
| By Discretionary | ||
| Discretionary | 4 | 537.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 537.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 196.2 | |
| United States Persons | 341.5 | |
| Total | 4 | 537.7 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Nathan Fischel | 3 | ||
| Fariba Ghodsian | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001389933] | |
| 3 | [0001389933] | |
| SC 13D | [0001389933] | |
| SC 13G | [0001389933] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| Stereotaxis, Inc. | |
| DAFNA Capital Management LLC | |
| Ghodsian Fariba Fischel |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
North Island Ventures LLC
✚
|
NY | 0.5 |
|
Truffle Hound Capital LLC
✚
|
MD | 0.5 |
|
Sherborne Investors Management LP
✚
|
NY | 0.5 |
|
TB Alternative Assets Ltd
✚
|
0.5 | |
|
Rings Capital Management LLC
✚
|
IL | 0.5 |
|
Thomist Capital Management LP
✚
|
TX | 0.5 |
|
Axon Capital LP
✚
|
NY | 0.5 |
|
Punch Card Management LP
✚
|
FL | 0.5 |
|
Blueshift Asset Management LLC
✚
|
NJ | 0.5 |
|
BeaconLight Capital LLC
✚
|
NY | 0.5 |